In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Unidym Inc.

Division of Arrowhead Pharmaceuticals Inc.

Latest From Unidym Inc.

Nexeon MedSystems Inc.

A new coronary stent made of cobalt alloy and coated with a thin layer of protein may provide a welcome alternative to traditional bare-metal or drug-eluting stents. When placed in the body, the prohealing PROTEX coronary stent system from Nexeon MedSystems is recognized by the body as having the architecture of a normal artery. Hence, according to the start-up, the body begins to populate the stent quickly with regular functioning cells, rather than reacting to the stent as a foreign metal. Because the thin, low-profile stent platform is biomimetic, rapid healing should occur.
Medical Device Platform Technologies

Deals Update (09/2007)

A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Nanotechnology, Chips, etc.
  • Medical Devices
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Arrowhead Pharmaceuticals Inc.
  • Senior Management
  • Art Swift, Pres. & CEO
    Joseph T Kingsley, CFO
    John Miller, VP, Bus. Dev.
  • Contact Info
  • Unidym Inc.
    Phone: (650) 462-1935
    1430 O'Brien Dr.
    Ste. G
    Menlo Park, CA 94025